{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:10:59Z","timestamp":1779088259611,"version":"3.51.4"},"reference-count":151,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cjco.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T06:13:11Z","timestamp":1657951991000},"page":"873-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiorenal Interactions: A Review"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-083X","authenticated-orcid":false,"given":"Sanam","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashani","family":"Lecamwasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Romanovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Bagshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janek Manoj","family":"Senaratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2022.06.011_bib1","first-page":"e154","volume":"112","author":"Hunt","year":"2005","journal-title":"endorsed by the Heart Rhythm Society. Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib2","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib4","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","article-title":"Terminology and definition of changes renal function in heart failure","volume":"34","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib5","first-page":"709","article-title":"Global, regional, and national burden of chronic kidney disease","volume":"395","year":"2020","journal-title":"a systematic analysis for the Global Burden of Disease Study 2017. Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ki.2014.293","article-title":"The growth of acute kidney injury: a rising tide or just closer attention to detail?","volume":"87","author":"Siew","year":"2015","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1016\/j.cjco.2022.06.011_bib7","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cjco.2022.06.011_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI: a meta-analysis","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib10","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2022.06.011_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib14","first-page":"307","article-title":"Acute kidney injury definition and diagnosis: a narrative review","volume":"7","author":"Gameiro","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the Consensus Conference of the Acute Dialysis Quality Initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb","year":"2002","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib19","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mnh.0000165894.90748.72","article-title":"Are small changes in serum creatinine an important risk factor?","volume":"14","author":"Praught","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cjco.2022.06.011_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine: Is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(17)30543-3","article-title":"Acute kidney injury: a problem of definition","volume":"389","author":"Barasch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.ajkd.2013.02.350","article-title":"Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","author":"James","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","author":"Palevsky","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib25","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","article-title":"A\u00a0European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy","volume":"27","author":"Fliser","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjco.2022.06.011_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(05)70238-5","article-title":"Acute renal failure","volume":"365","author":"Lameire","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.38975.657639.AE","article-title":"Acute renal failure","volume":"333","author":"Hilton","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2022.06.011_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1523-1755.2003_t01-1-00784.x","article-title":"Pathophysiology of pre-renal azotemia","volume":"53","author":"Blantz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00042.2012","article-title":"Renal autoregulation in health and disease","volume":"95","author":"Carlstrom","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjco.2022.06.011_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40560-017-0251-y","article-title":"Practical approach to detection and management of acute kidney injury in critically ill patient","volume":"5","author":"Mohsenin","year":"2017","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical renin-angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib32","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2006111302","article-title":"Decreased effective blood volume in edematous disorders: What does this mean?","volume":"18","author":"Schrier","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib33","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehx035","article-title":"Renal sodium avidity in heart failure: from pathophysiology to treatment strategies","volume":"38","author":"Mullens","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/phar.2440","article-title":"A\u00a0systematic review and meta-analysis of metolazone compared to chlorothiazide for treatment of acute decompensated heart failure","volume":"40","author":"Steuber","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjco.2022.06.011_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1074248413497257","article-title":"Diuretics: a review and update","volume":"19","author":"Roush","year":"2014","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cjco.2022.06.011_bib37","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiologoy, diagnosis, and treatment sstrategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1523-1755.1998.00051.x","article-title":"Differential upregulation of rat Na-K-Cl cotransporter, rBSC1, mRNA in the thick ascending limb of Henle in different pathological conditions","volume":"54","author":"Marumo","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib42","first-page":"450","article-title":"Response of the kidney to furosemide, I: effects of salt intake and renal compensation","volume":"102","author":"Wilcox","year":"1983","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.SMJ.0000149407.51134.77","article-title":"Extreme hyperkalemia","volume":"98","author":"Tran","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.cjco.2022.06.011_bib44","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines","volume":"158","author":"Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib45","first-page":"40","article-title":"Hyperkalemia revisited","volume":"33","author":"Parham","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cjco.2022.06.011_bib46","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/ndt\/gfg323","article-title":"Controversial issues in the treatment of hyperkalemia","volume":"18","author":"Kamel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjco.2022.06.011_bib47","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jelectrocard.2018.06.018","article-title":"Electrocardiographic manifestations of severe hyperkalemia","volume":"51","author":"Littmann","year":"2018","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000065375","article-title":"Therapeutic approach to hyperkalemia","volume":"92","author":"Kim","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.cjco.2022.06.011_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cen.14343","article-title":"Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia","volume":"94","author":"Tee","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cjco.2022.06.011_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/clc.20987","article-title":"Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy","volume":"35","author":"Chernin","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib51","first-page":"17","article-title":"PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016","volume":"8","author":"Buysse","year":"2012","journal-title":"FutureCardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrneph.2010.33","article-title":"Metabolic acidosis: pathophysiology, diagnosis and management","volume":"6","author":"Kraut","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1972.48","article-title":"The effects of acid-base disturbances on cardiovascular and pulmonary function","volume":"1","author":"Mitchell","year":"1972","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/jcem-59-3-398","article-title":"Rapid desensitization and uncoupling of human beta adrenergic receptors in an in\u00a0vitro model of lactic acidosis","volume":"59","author":"Davies","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2022.06.011_bib56","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cvr\/28.9.1312","article-title":"Acidosis and arrhythmias in cardiac muscle","volume":"28","author":"Orchard","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2022.06.011_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00000441-199602000-00001","article-title":"Effect of acute ketoacidosis on the myocardium in diabetes","volume":"311","author":"George","year":"1996","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cjco.2022.06.011_bib58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5414\/CN109401","article-title":"Uremia: a historical reappraisal of what happened","volume":"89","author":"Raghavan","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib59","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2013121264","article-title":"Approaches to uremia","volume":"25","author":"Meyer","year":"2014","journal-title":"JASN"},{"key":"10.1016\/j.cjco.2022.06.011_bib60","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/01.CIR.38.3.582","article-title":"Uremic pericarditis clinical features and management","volume":"38","author":"Bailey","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00000441-200304000-00009","article-title":"Pericardial involvement in end-stage renal disease","volume":"325","author":"Alpert","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cjco.2022.06.011_bib62","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib63","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2021.09.025","article-title":"Uremic encephalopathy","volume":"101","author":"Rosner","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0031-1277984","article-title":"Uremic encephalopathy and other brain disorders associated with renal failure","volume":"31","author":"Seifter","year":"2011","journal-title":"Semin Neurol"},{"key":"10.1016\/j.cjco.2022.06.011_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/S0103-507X2010000200016","article-title":"Mechanisms underlying uremic encephalopathy","volume":"22","author":"Scaini","year":"2010","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.cjco.2022.06.011_bib67","first-page":"408","article-title":"Biochemistry of uremia","volume":"37","author":"Schreiner","year":"1962","journal-title":"J\u00a0Med Educ"},{"key":"10.1016\/j.cjco.2022.06.011_bib68","first-page":"21","article-title":"Effects of urea loading in patients with far-advanced renal failure","volume":"47","author":"Johnson","year":"1972","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"10.1016\/j.cjco.2022.06.011_bib69","first-page":"S1","article-title":"Excerpts from the USRDS 2009 annual data report: atlas of end-stage renal disease in the United States","volume":"1","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/14779072.2019.1637254","article-title":"Defining the role of peritoneal dialysis in management of congestive heart failure","volume":"17","author":"Kazory","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cjco.2022.06.011_bib71","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013;3(suppl 1):1-150."},{"issue":"1 suppl 1","key":"10.1016\/j.cjco.2022.06.011_bib72","first-page":"S137","article-title":"III. NKF-K\/DOQI Clinical Practice Guidelines for Vascular Access: update 2000","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib73","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(06)69111-3","article-title":"Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial","volume":"368","author":"Vinsonneau","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib75","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/cc13188","article-title":"The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial","volume":"18","author":"Schefold","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib76","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.CCM.0B013E3181611F552","article-title":"Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis","volume":"36","author":"Bagshaw","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib77","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00134-016-4404-6","article-title":"Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery","volume":"42","author":"Truche","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00134-013-2864-5","article-title":"Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis","volume":"39","author":"Schneider","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.ajkd.2015.02.328","article-title":"Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis","volume":"66","author":"Zhang","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/039139880402700506","article-title":"Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians","volume":"27","author":"Naka","year":"2004","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cjco.2022.06.011_bib81","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00134-017-4762-8","article-title":"Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury","volume":"43","author":"Bagshaw","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib82","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/cc11682","article-title":"Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study","volume":"16","author":"Vaara","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib83","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"13","author":"Costanzo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib84","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/bjaed\/mkw070","article-title":"Renal replacement therapy in critical care","volume":"17","author":"Gemmell","year":"2017","journal-title":"BJA Education"},{"key":"10.1016\/j.cjco.2022.06.011_bib86","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjmed.2019.04.013","article-title":"Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and severe kidney disease or undergoing hemodialysis","volume":"132","author":"Coleman","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib87","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib89","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib90","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjco.2022.06.011_bib91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ndt\/gfn445","article-title":"Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study","volume":"24","author":"Campbell","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjco.2022.06.011_bib92","first-page":"1208","article-title":"Cardiorenal syndrome and heart failure\u2014challenges and opportunities","volume":"35","author":"Yogasundaram","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib94","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib95","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.ackd.2018.08.004","article-title":"Cardiorenal syndrome: an overview","volume":"25","author":"Ronco","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib96","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2013.250","article-title":"Cardiorenal syndrome\u2014current understanding and future perspectives","volume":"10","author":"Braam","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib98","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2005.07.016","article-title":"Pathophysiologic targets in the early phase of acute heart failure syndromes","volume":"96","author":"Gheorghiade","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib103","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2012.12.050","article-title":"The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure","volume":"61","author":"van der Meer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib104","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2022.06.011_bib106","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/j.1552-4604.1981.tb05684.x","article-title":"Clinical trial of bumetanide versus furosemide in patients with congestive heart failure","volume":"11","author":"Konecke","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cjco.2022.06.011_bib107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","article-title":"Metolazone in treatment of severe refractory congestive cardiac failure","volume":"335","author":"Kiyingi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib108","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/ejhf.1917","article-title":"Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis","volume":"22","author":"Kalogeropoulos","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib109","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2022.06.011_bib110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib111","first-page":"165","article-title":"Cardiac output monitoring: how to choose the optimal method for the individual patient","volume":"24","author":"Saugel","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib112","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib114","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2022.06.011_bib115","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2022.06.011_bib116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","article-title":"Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial","volume":"172","author":"Triposkiadis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib117","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2022.06.011_bib118","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib119","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2022.06.011_bib122","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000486629","article-title":"High right ventricular stroke work index is associated with worse kidney function in patients with heart failure with preserved ejection fraction","volume":"8","author":"Kanjanahattakij","year":"2018","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2005030270","article-title":"Kidney function and mortality among patients with left ventricular systolic dysfunction","volume":"17","author":"Khan","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib126","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib127","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib129","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2022.06.011_bib130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib131","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/ALN.0000000000000569","article-title":"Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications","volume":"122","author":"Lumb","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cjco.2022.06.011_bib132","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1469-7793.2000.00661.x","article-title":"The effect of acidosis on systolic Ca2+ and sarcoplasmic reticulum calcium content in isolated rat ventricular myocytes","volume":"529","author":"Choi","year":"2000","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib133","doi-asserted-by":"crossref","first-page":"C348","DOI":"10.1152\/ajpcell.1992.262.2.C348","article-title":"Contraction and intracellular Ca2+, Na+, and H+ during acidosis in rat ventricular myocytes","volume":"262","author":"Harrison","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib134","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/cc11468","article-title":"Mild metabolic acidosis impairs the beta-adrenergic response in isolated human failing myocardium","volume":"16","author":"Schotola","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-015-0896-7","article-title":"Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside","volume":"19","author":"Kimmoun","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib136","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yjmcc.2015.02.017","article-title":"Perspective: a dynamics-based classification of ventricular arrhythmias","volume":"82","author":"Weiss","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib137","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1046\/j.1523-1755.2001.00053.x","article-title":"Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function","volume":"60","author":"Periyasamy","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib138","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.53.5.896","article-title":"Uremic pericarditis as a cause of cardiac tamponade","volume":"53","author":"Baldwin","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0272-6386(87)80003-3","article-title":"Treatment of uremic pericarditis and pericardial effusion","volume":"10","author":"Rutsky","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2022.06.011_bib140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The pathogenesis of acute pulmonary edema associated with hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib141","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.02.024","volume":"47","author":"Hirsch","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib142","first-page":"506","article-title":"Hypertension Canada\u2019s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib143","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib144","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2022.06.011_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2007.00146.x","article-title":"Modification of cardiovascular risk in hemodialysis patients: an evidence-based review","volume":"11","author":"Johnson","year":"2007","journal-title":"Hemodial Int"},{"key":"10.1016\/j.cjco.2022.06.011_bib146","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0300-2977(96)00005-8","article-title":"The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients","volume":"48","author":"Janssen","year":"1996","journal-title":"Neth J Med"},{"key":"10.1016\/j.cjco.2022.06.011_bib147","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jth.13904","article-title":"Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study","volume":"16","author":"Ocak","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjco.2022.06.011_bib148","first-page":"443","article-title":"Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: insights from the TRILOGY ACS Trial","volume":"5","author":"Melloni","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2022.06.011_bib149","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.118.032078","article-title":"P2y12-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes","volume":"138","author":"Bonello","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2022.06.011_bib150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.amjcard.2011.11.052","article-title":"Relation between estimated glomerular filtration rate and composition of coronary arterial atherosclerotic plaques","volume":"109","author":"Hayano","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2022.06.011_bib151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2009.05.011","article-title":"Renal function, atherothrombosis extent, and outcomes in high-risk patients","volume":"158","author":"Dumaine","year":"2009","journal-title":"Am Heart J"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X22001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X22001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:10:19Z","timestamp":1762902619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X22001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":151,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2589790X22001354"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2022.06.011","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Interactions: A Review","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}